These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 11582513)

  • 1. CD8-deficient SJL mice display enhanced susceptibility to Theiler's virus infection and increased demyelinating pathology.
    Begolka WS; Haynes LM; Olson JK; Padilla J; Neville KL; Dal Canto M; Palma J; Kim BS; Miller SD
    J Neurovirol; 2001 Oct; 7(5):409-20. PubMed ID: 11582513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. VI. Potentiation of demyelination with and characterization of an immunopathologic CD4+ T cell line specific for an immunodominant VP2 epitope.
    Gerety SJ; Rundell MK; Dal Canto MC; Miller SD
    J Immunol; 1994 Jan; 152(2):919-29. PubMed ID: 7506740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional activation of myelin-specific T cells by virus-induced molecular mimicry.
    Olson JK; Eagar TN; Miller SD
    J Immunol; 2002 Sep; 169(5):2719-26. PubMed ID: 12193746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. V. Mapping of a dominant immunopathologic VP2 T cell epitope in susceptible SJL/J mice.
    Gerety SJ; Karpus WJ; Cubbon AR; Goswami RG; Rundell MK; Peterson JD; Miller SD
    J Immunol; 1994 Jan; 152(2):908-18. PubMed ID: 7904291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous presentation of self myelin epitopes by CNS-resident APCs in Theiler's virus-infected mice.
    Katz-Levy Y; Neville KL; Girvin AM; Vanderlugt CL; Pope JG; Tan LJ; Miller SD
    J Clin Invest; 1999 Sep; 104(5):599-610. PubMed ID: 10487774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of TGF-beta, IL-2, and other cytokines in the CNS of Theiler's murine encephalomyelitis virus-infected susceptible and resistant strains of mice.
    Chang JR; Zaczynska E; Katsetos CD; Platsoucas CD; Oleszak EL
    Virology; 2000 Dec; 278(2):346-60. PubMed ID: 11118358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The majority of infiltrating CD8+ T cells in the central nervous system of susceptible SJL/J mice infected with Theiler's virus are virus specific and fully functional.
    Kang BS; Lyman MA; Kim BS
    J Virol; 2002 Jul; 76(13):6577-85. PubMed ID: 12050370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral hyperinfection of the central nervous system and high mortality after hematopoietic stem cell transplantation for treatment of Theiler's murine encephalomyelitis virus-induced demyelinating disease.
    Burt RK; Padilla J; Dal Canto MC; Miller SD
    Blood; 1999 Oct; 94(8):2915-22. PubMed ID: 10515897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myelin-specific tolerance attenuates the progression of a virus-induced demyelinating disease: implications for the treatment of MS.
    Neville KL; Padilla J; Miller SD
    J Neuroimmunol; 2002 Feb; 123(1-2):18-29. PubMed ID: 11880145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CD4-mediated immune response is critical in determining the outcome of infection using Theiler's viruses with VP1 capsid protein point mutations.
    Rodriguez M; Roos RP; McGavern D; Zoecklein L; Pavelko K; Sang H; Lin X
    Virology; 2000 Sep; 275(1):9-19. PubMed ID: 11017783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal development of autoreactive Th1 responses and endogenous presentation of self myelin epitopes by central nervous system-resident APCs in Theiler's virus-infected mice.
    Katz-Levy Y; Neville KL; Padilla J; Rahbe S; Begolka WS; Girvin AM; Olson JK; Vanderlugt CL; Miller SD
    J Immunol; 2000 Nov; 165(9):5304-14. PubMed ID: 11046065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticapsid immunity level, not viral persistence level, correlates with the progression of Theiler's virus-induced demyelinating disease in viral P1-transgenic mice.
    Myoung J; Bahk YY; Kang HS; Dal Canto MC; Kim BS
    J Virol; 2008 Jun; 82(11):5606-17. PubMed ID: 18353953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. III. Failure of neuroantigen-specific immune tolerance to affect the clinical course of demyelination.
    Miller SD; Gerety SJ; Kennedy MK; Peterson JD; Trotter JL; Tuohy VK; Waltenbaugh C; Dal Canto MC; Lipton HL
    J Neuroimmunol; 1990 Jan; 26(1):9-23. PubMed ID: 1688446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocytes from mice chronically infected with Theiler's murine encephalomyelitis virus produce demyelination of organotypic cultures after stimulation with the major encephalitogenic epitope of myelin proteolipid protein. Epitope spreading in TMEV infection has functional activity.
    Dal Canto MC; Calenoff MA; Miller SD; Vanderlugt CL
    J Neuroimmunol; 2000 Apr; 104(1):79-84. PubMed ID: 10683517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFNγ influences type I interferon response and susceptibility to Theiler's virus-induced demyelinating disease.
    Bowen JL; Olson JK
    Viral Immunol; 2013 Aug; 26(4):223-38. PubMed ID: 23829778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4(+) and CD8(+) T cells make discrete contributions to demyelination and neurologic disease in a viral model of multiple sclerosis.
    Murray PD; Pavelko KD; Leibowitz J; Lin X; Rodriguez M
    J Virol; 1998 Sep; 72(9):7320-9. PubMed ID: 9696828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A predominant viral epitope recognized by T cells from the periphery and demyelinating lesions of SJL/J mice infected with Theiler's virus is located within VP1(233-244).
    Yauch RL; Kim BS
    J Immunol; 1994 Nov; 153(10):4508-19. PubMed ID: 7525707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral administration of live virus protects susceptible mice from developing Theiler's virus-induced demyelinating disease.
    Kang BS; Yahikozawa H; Koh CS; Kim BS
    Virology; 2007 Sep; 366(1):185-96. PubMed ID: 17507073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preservation of motor function by inhibition of CD8+ virus peptide-specific T cells in Theiler's virus infection.
    Johnson AJ; Upshaw J; Pavelko KD; Rodriguez M; Pease LR
    FASEB J; 2001 Dec; 15(14):2760-2. PubMed ID: 11606479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CNS expression of B7-H1 regulates pro-inflammatory cytokine production and alters severity of Theiler's virus-induced demyelinating disease.
    Duncan DS; Miller SD
    PLoS One; 2011 Apr; 6(4):e18548. PubMed ID: 21494618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.